These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24349418)

  • 41. Long QT Syndrome: Genetics and Future Perspective.
    Wallace E; Howard L; Liu M; O'Brien T; Ward D; Shen S; Prendiville T
    Pediatr Cardiol; 2019 Oct; 40(7):1419-1430. PubMed ID: 31440766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
    Matsa E; Rajamohan D; Dick E; Young L; Mellor I; Staniforth A; Denning C
    Eur Heart J; 2011 Apr; 32(8):952-62. PubMed ID: 21367833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple mechanisms underlie increased cardiac late sodium current.
    Kroncke BM; Yang T; Roden DM
    Heart Rhythm; 2019 Jul; 16(7):1091-1097. PubMed ID: 30677491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ion channels, long QT syndrome and arrhythmogenesis in ageing.
    Jeevaratnam K; Chadda KR; Salvage SC; Valli H; Ahmad S; Grace AA; Huang CL
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1(Suppl Suppl 1):38-45. PubMed ID: 28024120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrhythmias precede cardiomyopathy and remodeling of Ca
    Montnach J; Chizelle FF; Belbachir N; Castro C; Li L; Loussouarn G; Toumaniantz G; Carcouët A; Meinzinger AJ; Shmerling D; Benitah JP; Gómez AM; Charpentier F; Baró I
    J Mol Cell Cardiol; 2018 Oct; 123():13-25. PubMed ID: 30144447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.
    Nozaki Y; Honda Y; Tsujimoto S; Watanabe H; Kunimatsu T; Funabashi H
    Toxicol Appl Pharmacol; 2014 Jul; 278(1):72-7. PubMed ID: 24742750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
    N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.
    de la Rosa AJ; Domínguez JN; Sedmera D; Sankova B; Hove-Madsen L; Franco D; Aránega AE
    Cardiovasc Res; 2013 Jun; 98(3):504-14. PubMed ID: 23542581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
    Zhang T; Yong SL; Drinko JK; Popović ZB; Shryock JC; Belardinelli L; Wang QK
    Int J Cardiol; 2011 Mar; 147(2):239-45. PubMed ID: 19762097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3.
    Iyer V; Roman-Campos D; Sampson KJ; Kang G; Fishman GI; Kass RS
    Sci Rep; 2015 Aug; 5():13287. PubMed ID: 26289036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
    Kanters JK; Yuan L; Hedley PL; Stoevring B; Jons C; Bloch Thomsen PE; Grunnet M; Christiansen M; Jespersen T
    Circ J; 2014; 78(5):1136-43. PubMed ID: 24599044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
    Wedekind H; Smits JP; Schulze-Bahr E; Arnold R; Veldkamp MW; Bajanowski T; Borggrefe M; Brinkmann B; Warnecke I; Funke H; Bhuiyan ZA; Wilde AA; Breithardt G; Haverkamp W
    Circulation; 2001 Sep; 104(10):1158-64. PubMed ID: 11535573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
    Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
    Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.
    Zhang XH; Haviland S; Wei H; Sarić T; Fatima A; Hescheler J; Cleemann L; Morad M
    Cell Calcium; 2013 Aug; 54(2):57-70. PubMed ID: 23684427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.